8-K Filing
What is 8-K Filing?
An SEC filing that publicly traded companies must submit to announce major events that shareholders should know about.
Why does 8-K Filing matter?
An 8-K is the SEC's "breaking news" filing. Companies must file within four business days of a triggering event — CEO resignation, major acquisition, bankruptcy, delisting, or material impairment.
For biotech investors, 8-K filings are critical signals: clinical trial results, FDA decisions, licensing deals, and leadership changes all require 8-K disclosure.
Reading 8-K filings before the market digests them is one of the few legal edges in biotech investing. The filing hits EDGAR before the press release hits Bloomberg.
Related terms
Recent coverage
- Lumryz Hits Phase 3 Win, Expansion Filing Next May 12
- FDA Delays Leqembi SubQ Decision to August 24 May 8
- Viridian Soars 39% as Elegrobart Phase 3 Hits 54% PRR May 6
- Cleared 2 Phase 3 Trials, Incyte Plans Povorcitinib Vitiligo Filing Apr 28
- Ionis Filed Zilganersen for Sept. 22 FDA Decision; First AxD Drug Apr 23
The daily brief, 7am ET.
Every morning. The observations you'd rather not receive — before they hit your desk.
Request early access →hello@the483.com · Free